128 related articles for article (PubMed ID: 22709826)
41. [Studies on serum and urinary alpha 1-microglobulin levels as parameter of the renal function--renal function observed after CDDP administration].
Ujiie T; Maruta H; Ito N
Hinyokika Kiyo; 1988 May; 34(5):790-6. PubMed ID: 2459938
[TBL] [Abstract][Full Text] [Related]
42. Diquat induces renal proximal tubule injury in glutathione reductase-deficient mice.
Rogers LK; Bates CM; Welty SE; Smith CV
Toxicol Appl Pharmacol; 2006 Dec; 217(3):289-98. PubMed ID: 17078987
[TBL] [Abstract][Full Text] [Related]
43. Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat.
Houghton DC; Plamp CE; DeFehr JM; Bennett WM; Porter G; Gilbert D
Am J Pathol; 1978 Oct; 93(1):137-52. PubMed ID: 696801
[TBL] [Abstract][Full Text] [Related]
44. Effects of dietary cadmium on rhesus monkeys.
Nomiyama K; Nomiyama H; Nomura Y; Taguchi T; Matsui K; Yotoriyama M; Akahori F; Iwao S; Koizumi N; Masaoka T; Kitamura S; Tsuchiya K; Suzuki T; Kobayashi K
Environ Health Perspect; 1979 Feb; 28():223-43. PubMed ID: 114386
[TBL] [Abstract][Full Text] [Related]
45. Development of resistance against hexachlorobutadiene in the proximal tubules of young male rat.
Boroushaki MT
Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):367-75. PubMed ID: 15012908
[TBL] [Abstract][Full Text] [Related]
46. Renal cortical mitochondrial dysfunction upon cadmium metallothionein administration to Sprague-Dawley rats.
Tang W; Shaikh ZA
J Toxicol Environ Health A; 2001 Jun; 63(3):221-35. PubMed ID: 11405417
[TBL] [Abstract][Full Text] [Related]
47. Renal function during lithium treatment.
Waller DG; Edwards JG; Naik R; Polak A
Q J Med; 1984; 53(211):369-79. PubMed ID: 6484119
[TBL] [Abstract][Full Text] [Related]
48. Methyl mercury intoxication in rat kidneys. Functional and pathological changes.
Klein R; Herman SP; Bullock BC; Talley FA
Arch Pathol; 1973 Aug; 96(2):83-90. PubMed ID: 4718233
[No Abstract] [Full Text] [Related]
49. Effects of the angiotensin-converting enzyme inhibitor quinapril on renal function in rats.
Graziano MJ; Dethloff LA; Griffin HE; Pegg DG
Arch Int Pharmacodyn Ther; 1993; 324():87-104. PubMed ID: 8297189
[TBL] [Abstract][Full Text] [Related]
50. Development of renal function tests for measurement of urine concentrating ability, urine acidification, and glomerular filtration rate in female cynomolgus monkeys.
Weekley LB; Deldar A; Tapp E
Contemp Top Lab Anim Sci; 2003 May; 42(3):22-5. PubMed ID: 19760830
[TBL] [Abstract][Full Text] [Related]
51. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.
Henry SP; Templin MV; Gillett N; Rojko J; Levin AA
Toxicol Pathol; 1999; 27(1):95-100. PubMed ID: 10367680
[TBL] [Abstract][Full Text] [Related]
52. Distribution and excretion of a phosphorothioate oligonucleotide in rats with experimentally induced renal injury.
Masarjian L; de Peyster A; Levin AA; Monteith DK
Oligonucleotides; 2004; 14(4):299-310. PubMed ID: 15665597
[TBL] [Abstract][Full Text] [Related]
53. Renal Effects of Antisense-Mediated Inhibition of SGLT2.
van Meer L; Moerland M; van Dongen M; Goulouze B; de Kam M; Klaassen E; Cohen A; Burggraaf J
J Pharmacol Exp Ther; 2016 Nov; 359(2):280-289. PubMed ID: 27605629
[TBL] [Abstract][Full Text] [Related]
54. Therapy with 2'-O-Me Phosphorothioate Antisense Oligonucleotides Causes Reversible Proteinuria by Inhibiting Renal Protein Reabsorption.
Janssen MJ; Nieskens TTG; Steevels TAM; Caetano-Pinto P; den Braanker D; Mulder M; Ponstein Y; Jones S; Masereeuw R; den Besten C; Wilmer MJ
Mol Ther Nucleic Acids; 2019 Dec; 18():298-307. PubMed ID: 31610379
[TBL] [Abstract][Full Text] [Related]
55. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys.
Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP
Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080
[TBL] [Abstract][Full Text] [Related]
56. Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells.
Takao T; Horino T; Kagawa T; Matsumoto R; Shimamura Y; Ogata K; Inoue K; Taniguchi Y; Taguchi T; Morita T; Terada Y
J Nephrol; 2011; 24(2):218-24. PubMed ID: 20890878
[TBL] [Abstract][Full Text] [Related]
57. Electronic microscopy evidence for mitochondria as targets for Cd/Se/Te-based quantum dot 705 toxicity in vivo.
Lin CH; Chang LW; Wei YH; Wu SB; Yang CS; Chang WH; Chen YC; Lin PP
Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S53-62. PubMed ID: 22871604
[TBL] [Abstract][Full Text] [Related]
58. [Observation of penetration, distribution and accumulation in human renal proximal tubular epithelial cells by aristololactam-I].
Shang P; Wang X; Li XM; Tang JW; Cai SQ
Zhongguo Zhong Yao Za Zhi; 2008 Apr; 33(7):793-7. PubMed ID: 18589784
[TBL] [Abstract][Full Text] [Related]
59. Human embryonic stem cells differentiate into functional renal proximal tubular-like cells.
Narayanan K; Schumacher KM; Tasnim F; Kandasamy K; Schumacher A; Ni M; Gao S; Gopalan B; Zink D; Ying JY
Kidney Int; 2013 Apr; 83(4):593-603. PubMed ID: 23389418
[TBL] [Abstract][Full Text] [Related]
60. The renal effect of intravenous adenine in humans.
Roth GJ; Moore GL; Kline WE; Poskitt TR
Transfusion; 1975; 15(2):116-23. PubMed ID: 1091029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
